Autoimmune hepatitis (AIH) is a chronic hepatitis with an increasing incidence. The majority
of patients require life-long immunosuppression and incomplete treatment response is …

Background and aim The association between iron-metabolism-related variables and liver
fibrosis in chronic hepatitis C and nonalcoholic fatty liver disease is now well known …

Autoimmune hepatitis (AIH) is an inflammatory condition of the liver that has a multitude of
clinical presentations from chronic hepatitis to acute fulminant hepatitis. AIH diagnosis is …

Autoimmune hepatitis (AIH) is an acute or chronic inflammatory disease of the liver caused
by an immune response of unknown origin. It affects people from all ethnic groups …

Aims: AIH (AIH) is a disease that presents itself in various forms, ranging from
aminotransferase asymptomatic alteration, acute hepatitis to decompensated cirrhosis. Few …

Although autoimmune hepatitis (AIH) can be treated with corticosteroid-based first-line
therapy, incomplete remission is associated with progressive liver fibrosis. So far accepted …

Background & Aims High IgG levels are considered a hallmark of autoimmune hepatitis
(AIH). A subgroup of patients with AIH has IgG within the normal range despite evidence of …

Methods: This retrospective, observational, multicenter study included all patients with a
clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external …

Results Patients were classified into two groups; group A showed a complete response to
therapy (n= 22; 61%) and group B showed partial response/treatment failure (n= 14; 39%) …

Autoimmune hepatitis (AIH) is an inflammatory liver disease with diverse clinical spectrum,
which predominantly affects females. This review provides detailed comparisons of …